HRTX insider RSU conversion: 3,874 shares added; total 154,509
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Heron Therapeutics (HRTX) reported an insider equity change. EVP & Chief Development Officer William P. Forbes acquired 3,874 shares of common stock on 10/19/2025 via the conversion of restricted stock units (transaction code M). Following this event, he directly owns 154,509 shares of common stock. The filing also lists 34,869 derivative securities remaining as restricted stock units. Each RSU equals one share, and the RSUs vest in 16 equal quarterly installments beginning one quarter after 01/19/2024.
Positive
- None.
Negative
- None.
Insider Trade Summary
3,874 shares exercised/converted
Mixed
2 txns
Insider
Forbes William P
Role
EVP, Chief Development Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 3,874 | $0.00 | -- |
| Exercise | Common Stock | 3,874 | $0.00 | -- |
Holdings After Transaction:
Restricted Stock Units — 34,869 shares (Direct);
Common Stock — 154,509 shares (Direct)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).
FAQ
What insider transaction did HRTX report?
EVP & CDO William P. Forbes acquired 3,874 common shares on 10/19/2025 through RSU conversion (code M).
What RSUs remain for William P. Forbes at HRTX?
The filing shows 34,869 derivative securities remaining as restricted stock units.
How do the HRTX RSUs vest for this grant?
They vest in 16 equal quarterly installments beginning one quarter after 01/19/2024.
What does transaction code M mean in this context?
Code M indicates a conversion of a derivative security, here RSUs converting into common shares at $0.00 per unit.